All Stories

  1. S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5

    Article • Microorganisms, February 2024, MDPI AG

    Dr Christian R Kahlert, Dr Thomas Bodmer

  2. SARS-CoV-2 Nucleocapsid Protein Mutations Found in Switzerland Disrupt N-Gene Amplification in Commonly Used Multiplex RT-PCR Assay

    Article • Pathogens, November 2023, MDPI AG

    Dr Thomas Bodmer

  3. Comparison of an automated DNA extraction and 16S rDNA real time PCR/sequencing diagnostic method using optimized reagents with culture during a 15-month study using specimens from sterile body sites

    Article • BMC Microbiology, May 2022, Springer Science + Business Media

    Dr Thomas Bodmer

  4. Carbapenemase-producing Klebsiella pneumoniae strains in Switzerland: human and non-human settings may share high-risk clones

    Article • Journal of Global Antimicrobial Resistance, March 2022, Elsevier

    Dr Thomas Bodmer

  5. Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland

    Article • Epidemics, December 2021, Elsevier

    Dr Thomas Bodmer

  6. Exploring the Global Spread of Klebsiella grimontii Isolates Possessing bla VIM-1 and mcr-9

    Article • Antimicrobial Agents and Chemotherapy, August 2021, ASM Journals

    Dr Thomas Bodmer

  7. Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report

    Article • Annals of Clinical Microbiology and Antimicrobials, August 2021, Springer Science + Business Media

    Dr Thomas Bodmer

  8. Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Clostridioides difficile

    Article • Frontiers in Cellular and Infection Microbiology, June 2021, Frontiers

    Dr Thomas Bodmer

  9. First report of a blaVIM-1 metallo-β-lactamase-possessing Klebsiella michiganensis

    Article • Journal of Global Antimicrobial Resistance, June 2021, Elsevier

    Dr Thomas Bodmer

  10. Characterisation of a new blaVIM-1-carrying IncN2 plasmid from an Enterobacter hormaechei subsp. steigerwaltii

    Article • Journal of Global Antimicrobial Resistance, March 2021, Elsevier

    Dr Thomas Bodmer

  11. Can antibody tests accurately detect prior SARS-CoV-2 infection?

    Article • Disease Markers, January 2021, Hindawi Publishing Corporation

    Dr Christian R Kahlert, Dr Thomas Bodmer

  12. Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori

    Article • Frontiers in Cellular and Infection Microbiology, December 2020, Frontiers

    Dr Peter Michael Keller, Dr Thomas Bodmer

  13. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study

    Article • Journal of Clinical Medicine, December 2020, MDPI AG

    Dr Christian R Kahlert, Dr Thomas Bodmer

  14. Preoperative decolonization and periprosthetic joint infections—A randomized controlled trial with 2‐year follow‐up

    Article • Journal of Orthopaedic Research®, December 2020, Wiley

    Dr Thomas Bodmer

  15. Successful management of a Clostridioides difficile ribotype 027 outbreak with a lean intervention bundle

    Article • Journal of Hospital Infection, October 2020, Elsevier

    Dr Thomas Bodmer

  16. Rapid Increase of CTX-M-Producing Shigella sonnei Isolates in Switzerland Due to Spread of Common Plasmids and International Clones

    Article • Antimicrobial Agents and Chemotherapy, September 2020, ASM Journals

    Dr Peter Michael Keller, Dr Thomas Bodmer

  17. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2020, De Gruyter

    Dr Christian R Kahlert, Dr Thomas Bodmer

  18. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)

    Article • Diagnostics, August 2020, MDPI AG

    Dr Christian R Kahlert, Dr Thomas Bodmer

  19. Impact of Bacterial Toxins in the Lungs

    Article • Toxins, April 2020, MDPI AG

    Dr Thomas Bodmer

  20. Does Preoperative Decolonization Reduce Surgical Site Infections in Elective Orthopaedic Surgery? A Prospective Randomized Controlled Trial

    Article • Clinical Orthopaedics and Related Research, January 2020, Wolters Kluwer Health

    Dr Thomas Bodmer

  21. Temporal Course of SARS‐CoV‐2 Antibody Positivity in Patients with COVID‐19 following the First Clinical Presentation

    Article • BioMed Research International, January 2020, Wiley

    Dr Christian R Kahlert, Dr Thomas Bodmer

  22. Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin

    Article • PLOS One, April 2018, PLOS

    Dr Francis A Mhimbira, Dr Thomas Bodmer

  23. Evaluation of a Multiplex Real-Time PCR Assay for Detecting Major Bacterial Enteric Pathogens in Fecal Specimens: Intestinal Inflammation and Bacterial Load Are Correlated in Campylobacter Infections

    Article • Journal of Clinical Microbiology, June 2016, ASM Journals

    Dr Thomas Bodmer , Lorenz Risch, Dr Thomas Bodmer

  24. Diagnose Inflammation Using More Than One Lab Specialities

    Article • Mediators of Inflammation, January 2016, Hindawi Publishing Corporation

    Lorenz Risch, Professor Urs Ernest Nydegger, Dr Thomas Bodmer

  25. Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland

    Article • Antimicrobial Agents and Chemotherapy, July 2015, ASM Journals

    Dr Thomas Bodmer

  26. Implementation of the Stop TB strategy in a large TB hospital in Ukraine: achievements and deficiencies

    Article • The International Journal of Tuberculosis and Lung Disease, April 2015, International Union Against Tuberculosis and Lung Disease

    Dr Thomas Bodmer

  27. Tracking a Tuberculosis Outbreak Over 21 Years: Strain-Specific Single-Nucleotide Polymorphism Typing Combined With Targeted Whole-Genome Sequencing

    Article • The Journal of Infectious Diseases, October 2014, Oxford University Press (OUP)

    Dr Thomas Bodmer

  28. Molecular epidemiology of tuberculosis in Cambodian children

    Article • Epidemiology and Infection, July 2014, Cambridge University Press

    Dr Thomas Bodmer

  29. Multilocus sequence typing scheme for the Mycobacterium abscessus complex

    Article • Research in Microbiology, February 2014, Elsevier

    Dr Sylvain Brisse, Dr Sylvia C Leao, Dr Thomas Bodmer

  30. IGRA-positive patients and interferon-gamma/interleukin-2 signatures: Can the Fluorospot assay provide further information?

    Article • Infection, January 2014, Springer Science + Business Media

    Dr Thomas Bodmer

  31. OXA-48 Carbapenemase-Producing Salmonella enterica Serovar Kentucky Isolate of Sequence Type 198 in a Patient Transferred from Libya to Switzerland

    Article • Antimicrobial Agents and Chemotherapy, January 2014, ASM Journals

    Andrea Endimiani, Dr Thomas Bodmer

  32. The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis

    Article • European Journal of Pediatrics, September 2013, Springer Science + Business Media

    Dr Thomas Bodmer

  33. HIV Infection Disrupts the Sympatric Host–Pathogen Relationship in Human Tuberculosis

    Article • PLoS Genetics, March 2013, PLOS

    Lukas Fenner, Dr Thomas Bodmer

  34. Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Article • Journal of Visualized Experiments, April 2012, MyJove Corporation

    Dr Thomas Bodmer

  35. Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, April 2012, ASM Journals

    Dr Thomas Bodmer

  36. Laboratory diagnosis of tuberculosis in a large pediatric hospital in Cambodia

    Article • The International Journal of Tuberculosis and Lung Disease, April 2012, International Union Against Tuberculosis and Lung Disease

    Dr Thomas Bodmer

  37. Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes

    Article • PLOS One, March 2012, PLOS

    Lukas Fenner, Dr Thomas Bodmer

  38. Pulmonary Disease due toMycobacterium tuberculosisin a Horse: Zoonotic Concerns and Limitations of Antemortem Testing

    Article • Veterinary Medicine International, January 2012, Hindawi Publishing Corporation

    Dr Thomas Bodmer

  39. Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV Infection

    Article • Journal of Clinical Microbiology, November 2011, ASM Journals

    Dr Thomas Bodmer

  40. “Pseudo-Beijing”: Evidence for Convergent Evolution in the Direct Repeat Region of Mycobacterium tuberculosis

    Article • PLOS One, September 2011, PLOS

    Lukas Fenner, Dr Thomas Bodmer

  41. Genotypic Diversity and Drug Susceptibility Patterns among M. tuberculosis Complex Isolates from South-Western Ghana

    Article • PLOS One, July 2011, PLOS

    Dr Thomas Bodmer

  42. Clinical Significance of Interleukin-2/Gamma Interferon Ratios in Mycobacterium tuberculosis-Specific T-Cell Signatures

    Article • Clinical and Vaccine Immunology, June 2011, ASM Journals

    Dr Thomas Bodmer

  43. Accidental infection of veterinary personnel with Mycobacterium tuberculosis at necropsy: A case study

    Article • Veterinary Microbiology, May 2011, Elsevier

    Dr Thomas Bodmer

  44. Mycobacterium Microti Infection in the Cat

    Article • Journal of Feline Medicine and Surgery, March 2011, SAGE Publications

    Dr Thomas Bodmer

  45. Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains

    Article • Journal of Clinical Microbiology, November 2010, ASM Journals

    Dr Thomas Bodmer

  46. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis

    Article • Journal of Perinatal Medicine, January 2009, De Gruyter

    Dr Thomas Bodmer

  47. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

    Article • European Respiratory Journal, August 2008, European Respiratory Society (ERS)

    Dr Thomas Bodmer

  48. Whole-Blood Interferon-Gamma Release Assay for Baseline Tuberculosis Screening of Healthcare Workers at a Swiss University Hospital

    Article • Infection Control, July 2008, Cambridge University Press

    Dr Thomas Bodmer

  49. Tuberculosis in a Swiss army training camp: contact investigation using an Interferon gamma release assay

    Article • Swiss Medical Weekly, May 2008, SMW Supporting Association

    Dr Thomas Bodmer

  50. Klinische Präsentation und Therapie der Mycobacterium-marinum-Infektion anhand von 12 Fallbeispielen

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2008, Thieme Publishing Group

    Dr Thomas Bodmer

  51. Partial overlap of anti-mycobacterial, and anti- Saccharomyces cerevisiae mannan antibodies in Crohn's disease

    Article • World Journal of Gastroenterology, January 2008, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Thomas Bodmer

  52. Interferon-γ-Release-Assays in der Tuberkulosediagnostik

    Article • Der Internist, May 2007, Springer Science + Business Media

    Dr Thomas Bodmer

  53. Use of the Immunodominant 18-Kilodalton Small Heat Shock Protein as a Serological Marker for Exposure to Mycobacterium ulcerans

    Article • Clinical and Vaccine Immunology, October 2006, ASM Journals

    Dr Thomas Bodmer

  54. Dynamics of Hemodialysis Catheter Colonization by Coagulase-Negative Staphylococci

    Article • Infection Control, June 2005, Cambridge University Press

    Dr Thomas Bodmer

  55. Polyphasic Approach for Identifying Bacillus spp.

    Article • Journal of Clinical Microbiology, February 2005, ASM Journals

    Dr Thomas Bodmer

  56. Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum

    Article • Journal of Microbiological Methods, January 2005, Elsevier

    Dr Thomas Bodmer

  57. Evaluation of Decontamination Methods and Growth Media for Primary Isolation of Mycobacterium ulcerans from Surgical Specimens

    Article • Journal of Clinical Microbiology, December 2004, ASM Journals

    Dr Thomas Bodmer

  58. Failure of Ceftriaxone in an Intravenous Drug User with Invasive Infection Due to Ralstonia pickettii

    Article • Infection, August 2004, Springer Science + Business Media

    Dr Thomas Bodmer

  59. Multicenter Evaluation of the MB/BACT System for Susceptibility Testing of Mycobacterium tuberculosis

    Article • Journal of Clinical Microbiology, March 2004, ASM Journals

    Dr Thomas Bodmer

  60. Development and Application of Real-Time PCR Assay for Quantification of Mycobacterium ulcerans DNA

    Article • Journal of Clinical Microbiology, September 2003, ASM Journals

    Dr Thomas Bodmer

  61. Nocardiacyriacigeorgici: Erstbeschreibung als invasive Infektion

    Article • DMW - Deutsche Medizinische Wochenschrift, May 2003, Thieme Publishing Group

    Dr Thomas Bodmer

  62. Clinical Implications of Mycobacterium kansasii Species Heterogeneity: Swiss National Survey

    Article • Journal of Clinical Microbiology, March 2003, ASM Journals

    Dr Thomas Bodmer

  63. Nationwide Surveillance of NasopharyngealStreptococcus pneumoniaeIsolates from Children with Respiratory Infection, Switzerland, 1998–1999

    Article • The Journal of Infectious Diseases, February 2003, Oxford University Press (OUP)

    Dr Thomas Bodmer

  64. Mycobacterium bohemicum cervical lymphadenitis

    Article • The Pediatric Infectious Disease Journal, October 2002, Wolters Kluwer Health

    Dr Thomas Bodmer

  65. Comparison of phenotypic and genotypic methods for the detection of clarithromycin resistance in Mycobacterium avium

    Article • Journal of Antimicrobial Chemotherapy, April 2002, Oxford University Press (OUP)

    Dr Thomas Bodmer

  66. Nocardial Brain Abscess: Observation of Treatment Strategies and Outcome in Switzerland from 1992 to 1999

    Article • Infection, December 2001, Springer Science + Business Media

    Dr Thomas Bodmer

  67. Mycobacterium genavense infection in a patient with long‐standing chronic lymphocytic leukaemia

    Article • Journal of Internal Medicine, October 2000, Wiley

    Dr Thomas Bodmer

  68. Mycobacterium szulgai Keratitis

    Article • Archives of Ophthalmology, August 2000, American Medical Association (AMA)

    Dr Thomas Bodmer

  69. Mycobacterium aviumresists exposure to the acidic conditions of the stomach

    Article • FEMS Microbiology Letters, January 2000, Oxford University Press (OUP)

    Dr Thomas Bodmer

  70. Characterization of IS666, a Newly Described Insertion Element ofMycobacterium avium

    Article • Microbial & Comparative Genomics, January 2000, Mary Ann Liebert Inc

    Dr Thomas Bodmer

  71. Molecular Epidemiology of Tuberculosis among HIV-Infected Persons in Switzerland: A Countrywide 9-Year Cohort Study

    Article • Infection, December 1999, Springer Science + Business Media

    Dr Thomas Bodmer

  72. IS 1245 Restriction Fragment Length Polymorphism Typing of Mycobacterium avium Isolates: Proposal for Standardization

    Article • Journal of Clinical Microbiology, October 1998, ASM Journals

    Dr Thomas Bodmer

  73. Phenotypes of resistance to macrolide and lincosamide antibiotics in Staphylococcus species

    Article • Clinical Microbiology and Infection, December 1997, Elsevier

    Dr Thomas Bodmer

  74. Evaluation of the COBAS AMPLICOR MTB system

    Article • Journal of Clinical Microbiology, June 1997, ASM Journals

    Dr Thomas Bodmer

  75. Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov

    Article • Journal of Clinical Microbiology, May 1996, ASM Journals

    Dr Thomas Bodmer

  76. Improved performance of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test when 500 instead of 50 microliters of decontaminated sediment is used

    Article • Journal of Clinical Microbiology, January 1996, ASM Journals

    Dr Thomas Bodmer

  77. Comparison of random amplified polymorphic DNA with restriction fragment length polymorphism as epidemiological typing methods for Mycobacterium tuberculosis

    Article • Molecular Pathology, June 1995, BMJ

    Dr Thomas Bodmer

  78. Evaluation of the relatedness of strains ofMycobacterium avium using pulsed-field gel electrophoresis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 1995, Springer Science + Business Media

    Dr Thomas Bodmer

  79. A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness

    Article • Journal of Clinical Microbiology, February 1995, ASM Journals

    Dr Thomas Bodmer

  80. Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis

    Article • Journal of Antimicrobial Chemotherapy, January 1995, Oxford University Press (OUP)

    Dr Thomas Bodmer

  81. Genotypic characterization of Mycobacterium avium strains recovered from animals and their comparison to human strains

    Article • Applied and Environmental Microbiology, January 1995, ASM Journals

    Dr Thomas Bodmer

  82. Screening of respiratory tract specimens for the presence of Mycobacterium tuberculosis by using the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test

    Article • Journal of Clinical Microbiology, June 1994, ASM Journals

    Dr Thomas Bodmer

  83. Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare

    Article • Journal of Antimicrobial Chemotherapy, January 1994, Oxford University Press (OUP)

    Dr Thomas Bodmer

  84. Permeation of human chorioamniotic membranes by Escherichia coli in vitro

    Article • American Journal of Obstetrics and Gynecology, January 1994, Elsevier

    Dr Thomas Bodmer

  85. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis.

    Article • Antimicrobial Agents and Chemotherapy, October 1993, ASM Journals

    Dr Thomas Bodmer

  86. Molecular approach to identifying route of transmission of tuberculosis in the community

    Article • The Lancet, October 1993, Elsevier

    Dr Thomas Bodmer

  87. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

    Article • The Lancet, March 1993, Elsevier

    Dr Thomas Bodmer

  88. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis

    Article • Journal of Clinical Microbiology, February 1993, ASM Journals

    Dr Thomas Bodmer

  89. Invasive infection withMycobacterium genavense in three children with the acquired immunodeficiency syndrome

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 1993, Springer Science + Business Media

    Dr Thomas Bodmer

  90. Successful Treatment of Disseminated Nocardiosis Complicated by Cerebral Abscess with Ceftriaxone and Amikacin: Case Report

    Article • Clinical Infectious Diseases, December 1992, Oxford University Press (OUP)

    Dr Thomas Bodmer